Better safe than sorry: As of February 2019, new regulations have been implemented against the falsification of medicines in the EU. Usually containing ingredients of bad or toxic quality, these pharmaceuticals pose a real risk to public health. As falsified medicines become more sophisticated and harder to track, how can the EU further ensure the safety of consumers all over Europe?